Clinical relevance of hepatitis B core total antibody in the detection of occult hepatitis B infection in patients with liver disease and blood donors

QR Code

Clinical relevance of hepatitis B core total antibody in the detection of occult hepatitis B infection in patients with liver disease and blood donors

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Vijeta Bajpai, Ekta Gupta, Aashish Chaudhary, Meenu Bajpai
Format:	article
Langue:	EN
Publié:	Wolters Kluwer Medknow Publications 2021
Sujets:	Diseases of the blood and blood-forming organs RC633-647.5
Accès en ligne:	https://doaj.org/article/f0a3d8a47f2a403a8a1d7c666f4cc823
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Frequency of hepatitis B virus-DNA among hepatitis B surface-Ag negative, anti-hepatitis B core antibody-positive blood donors in Yazd, Iran
par: Mahtab Vaziri, et autres
Publié: (2021)

MicroRNAs as B-cell lymphoma biomarkers
par: Manterola L, et autres
Publié: (2015)

MicroRNA dysregulation in B-cell non-Hodgkin lymphoma
par: Lim EL, et autres
Publié: (2013)

Immune targeted therapy for diffuse large B cell lymphoma
par: Yaxin Zheng, et autres
Publié: (2021)

TREATMENT OF RELAPSED, REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA
par: Ebru Pekgüç, et autres
Publié: (2021)

INAPPROPRIATE ADH SYNDROME OCCURING DURING B-ALL TREATMENT
par: Merih Reis Aras, et autres
Publié: (2021)

Unexpected debris after post thawing donor stem cells in autologous transplantation
par: Basak Adaklı Aksoy, et autres
Publié: (2021)

THE FREQUENCY OF HLA-A, B AND DRB1 ALLELES IN PATIENTS WITH BETA THALASSEMIA
par: Zeynep Karakas, et autres
Publié: (2021)

Primary dural high grade B cell lymphoma mimicking subdural hematoma
par: Aya Nakaya, et autres
Publié: (2021)

Treatment strategies for patients with diffuse large B-cell lymphoma: past, present, and future
par: Flowers CR, et autres
Publié: (2012)

AN UNUSUAL SURVIVING HISTORY: MULTISYSTEM INVOLVEMENT UNTIL ADULT LIFE WITH NIEMANN PICK TYPE B
par: Özden ÖZLÜK, et autres
Publié: (2021)

B-cell malignancies: capture-sequencing strategies for identification of gene rearrangements and translocations into immunoglobulin gene loci
par: Boyle EM, et autres
Publié: (2014)

A CASE OF STAGE 1E DIFFUSE LARGE B-CELL LYMPHOMA PRESENTED WITH KNEE INVOLVEMENT
par: Mesut Tığlıoğlu, et autres
Publié: (2021)

B1-CELLS OF INNATE IMMUNITY IN THE BONE MARROW IN BREAST CANCER PATIENTS: IDENTIFICATION AND THEIR RELATIONSHIP WITH CLINICAL AND MORPHOLOGICAL PARAMETERS
par: Svetlana Chulkova, et autres
Publié: (2021)

The European Medicines Agency Review of Tafasitamab in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
par: Julio Delgado, et autres
Publié: (2021)

A REGISTRY-BASED, OBSERVATIONAL SAFETY STUDY OF INOTUZUMAB OZOGAMICIN (INO) IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PROCEEDING TO HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
par: David MARKS, et autres
Publié: (2021)

Clinical potential of carfilzomib in the treatment of relapsed and refractory multiple myeloma
par: Gupta VA, et autres
Publié: (2013)

Cardiovascular risk factors are associated with augmented thrombogenicity in healthy individuals: analysis using the Total Thrombus-formation Analysis System
par: Yuu Oda, et autres
Publié: (2021)

A Rare Cause of Acquired Factor X Deficiency in an 87-Year-Old Female
par: Ayrton Bangolo, et autres
Publié: (2021)

Trends in the treatment of cutaneous T-cell lymphoma &ndash; critical evaluation and perspectives on vorinostat
par: Zhang CL, et autres
Publié: (2012)

Critical appraisal of belinostat in the management of T-cell lymphoma – patient considerations
par: Bodiford A, et autres
Publié: (2015)

The expanding role of bendamustine in chronic lymphocytic leukemia
par: Nair KS, et autres
Publié: (2015)

Bortezomib in autoimmune hemolytic anemia and beyond
par: Raffaella Pasquale, et autres
Publié: (2021)

Life-Threatening Retroperitoneal Hematoma in a Patient with COVID-19
par: Monarch Shah, et autres
Publié: (2021)

A method to determine if more than surrogate outcomes were improved: The EMR glitch experiment
par: Jennifer Gill, et autres
Publié: (2020)

All bleeding matters … but the details may not
par: Sarah H. O’Brien
Publié: (2020)

The Use of Etoposide, Ara-Cytarabine, and Melphalan (EAM) Conditioning Chemotherapy in Autologous Stem Cell Transplantation (ASCT) for a Patient with Relapsed Hodgkin’s Lymphoma
par: Eko A. Pangarsa, et autres
Publié: (2021)

PP Transcon 2020 Abstracts Compilation
Publié: (2021)

Positive/external control of rapid diagnostic tests: A step forward in malaria screening
par: Rasika D Setia, et autres
Publié: (2021)

A rare case of mistaken identity - Historical blood group saved the situation
par: Anand Deshpande, et autres
Publié: (2021)

Oration - Dr Sanmukh Joshi
Publié: (2021)

OP Transcon 2020 Abstracts Compilation
Publié: (2021)

TRANSCON 2020 45th Annual Conference ISBTI 27th & 28th Feb 2021
Publié: (2021)

Long-term safety and efficacy of dasatinib in the treatment of chronic-phase chronic myeloid leukemia patients resistant or intolerant to imatinib
par: Shoumariyeh K, et autres
Publié: (2014)

MYC as therapeutic target in leukemia and lymphoma
par: Cortiguera MG, et autres
Publié: (2015)

Optimal management of endemic Burkitt lymphoma: a holistic approach mindful of limited resources
par: Moormann AM, et autres
Publié: (2014)

Peripheral T cell lymphoma: clinical utility of romidepsin
par: Sawey K, et autres
Publié: (2012)

The evaluation and optimal use of rituximab in lymphoid malignancies
par: Smolewski P, et autres
Publié: (2012)

Impact of pharmacokinetics to reduce bleeding in a cohort of patients with severe hemophilia A in a personalized comprehensive management program
par: Samuel sarmiento Doncel, et autres
Publié: (2021)

Ultrastructural alterations of megakaryocytes in thrombocytopenia: A review of 43 cases
par: Brian Eyden, et autres
Publié: (2021)